Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Clinical Genetics
|
July 30, 2011
Two novel germline KRAS mutations: expanding the molecular and clinical phenotype
Z Stark, G Gillessen-Kaesbach, M M Ryan, et al.
Genetic Counseling (Geneva, Switzerland)
|
June 6, 2015
A novel mutation in the FRAS1 gene in a patient with Fraser syndrome
S Ozemri Sag, O Gorukmez, O Gorukmez, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 10, 2012
Cellular and molecular properties of (90)Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitro
M Saki, M Toulany, W Sihver, et al.
Clinical Genetics
|
March 17, 2012
Clinical and molecular analysis of RASopathies in a group of Turkish patients
P Ö Şimşek-Kiper, Y Alanay, B Gülhan, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
August 30, 2012
Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation
M Ingargiola, C Dittfeld, R Runge, et al.
Leukemia
|
March 16, 2007
Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome
A Karow, D Steinemann, G Göhring, et al.
Clinical Genetics
|
January 31, 2012
A puzzle over several decades: eye anomalies with FRAS1 and STRA6 mutations in the same family
W Y Ng, F Pasutto, T M Bardakjian, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
June 5, 2008
Infantile hypophosphatasia due to a new compound heterozygous TNSALP mutation - functional evidence for a hydrophobic side-chain?
B Utsch, I Brun-Heath, G Staatz, et al.
American Journal of Human Genetics
|
October 16, 1999
Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia
I Quack, B Vonderstrass, M Stock, et al.
Kidney International
|
August 17, 2006
Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders
K Hasselbacher, R C Wiggins, V Matejas, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Clinical Genetics
|
July 30, 2011
Two novel germline KRAS mutations: expanding the molecular and clinical phenotype
Z Stark, G Gillessen-Kaesbach, M M Ryan, et al.
Genetic Counseling (Geneva, Switzerland)
|
June 6, 2015
A novel mutation in the FRAS1 gene in a patient with Fraser syndrome
S Ozemri Sag, O Gorukmez, O Gorukmez, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 10, 2012
Cellular and molecular properties of (90)Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitro
M Saki, M Toulany, W Sihver, et al.
Clinical Genetics
|
March 17, 2012
Clinical and molecular analysis of RASopathies in a group of Turkish patients
P Ö Şimşek-Kiper, Y Alanay, B Gülhan, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
August 30, 2012
Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation
M Ingargiola, C Dittfeld, R Runge, et al.
Leukemia
|
March 16, 2007
Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome
A Karow, D Steinemann, G Göhring, et al.
Clinical Genetics
|
January 31, 2012
A puzzle over several decades: eye anomalies with FRAS1 and STRA6 mutations in the same family
W Y Ng, F Pasutto, T M Bardakjian, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
June 5, 2008
Infantile hypophosphatasia due to a new compound heterozygous TNSALP mutation - functional evidence for a hydrophobic side-chain?
B Utsch, I Brun-Heath, G Staatz, et al.
American Journal of Human Genetics
|
October 16, 1999
Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia
I Quack, B Vonderstrass, M Stock, et al.
Kidney International
|
August 17, 2006
Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders
K Hasselbacher, R C Wiggins, V Matejas, et al.
Page
of 6